Nusinersen (Spinraza®). HTA ID: 20044

Assessment Status Rapid Review Complete
HTA ID 20044
Drug Nusinersen
Brand Spinraza®
Indication For the treatment of 5q spinal muscular atrophy (SMA) in adults patients (>18 years).
Assessment Process
Rapid review commissioned 28/09/2020
Rapid review completed 29/10/2020
Rapid review outcome A full HTA is recommended to assess the clinical and cost-effectiveness compared to the current standard of care.